

Ocugen (NASDAQ:OCGN) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been provided...
You can purchase shares of Ocugen (NASDAQ:OCGN) through any online brokerage.
Other companies in Ocugen’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Ocugen has a consensus price target of $8.30.
The stock price for Ocugen (NASDAQ: OCGN) is $0.9312 last updated November 6, 2026 at 7:59 PM EST.
There are no upcoming dividends for Ocugen.
Ocugen does not have any upcoming earnings scheduled.
There is no upcoming split for Ocugen.
Ocugen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform,...